Biopsy markers of airway inflammation and remodelling

Respiratory Medicine

Volumn 94, Issue , 2000, Pages S9-S15

  Jeffery, P K ^a   Laitinen, A ^b   Venge, P ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Asthma; Biopsy; Inflammation; Remodelling

Indexed keywords

CARBON DIOXIDE; CD68 ANTIGEN; CHEMOKINE; CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; EOTAXIN; ETHANE; FIBRONECTIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROGEN PEROXIDE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; LIPOCALIN; MUCIN; MYELOPEROXIDASE; NITRIC OXIDE; PEROXIDASE; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC ASTHMA; ARTICLE; ASTHMA; ATOPY; BASEMENT MEMBRANE; BLOOD ANALYSIS; BRONCHITIS; BRONCHUS BIOPSY; BRONCHUS MUSCLE; CELL ULTRASTRUCTURE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE RELEASE; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DISEASE SEVERITY; EOSINOPHIL; EXPIRED AIR; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; INFLAMMATORY INFILTRATE; LUNG LAVAGE; MAST CELL; MUSCLE CELL; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SPUTUM ANALYSIS; T LYMPHOCYTE ACTIVATION; URINALYSIS;

ASTHMA; BIOLOGICAL MARKERS; BIOPSY; BRONCHITIS; CHRONIC DISEASE; GROWTH SUBSTANCES; HUMANS; MUCUS; MUSCLE, SMOOTH; PHENOTYPE;

EID: 0033765726     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(00)90127-6     Document Type: Article

References (64)

1. Eosinophilic inflammation in asthma
2. Mechanism of airway inflammation in asthma
3. Structural and inflammatory changes in COPD: A comparison with asthma
4. Airways remodelling is a distinctive feature of asthma and is related to severity of disease
5. Asthma. From bronchoconstriction to airways inflammation and remodeling
6. How to measure airway inflammation: Bronchoalveolar lavage and airway biopsies
7. Methods for assessment of airways inflammation
8. Bronchial biopsies and airway inflammation
9. Bronchial mucosal manifestations of atopy: A comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls
10. The eosinophilic leukocyte and the pathology of fatal bronchial asthma: Evidence for pathologic heterogeneity
11. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma
12. T lymphocytes and activated eosinophils in asthma and cystic fibrosis
13. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial
14. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma
15. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: Relationship to the macrophage-colony-stimulating factor, and IL-3
16. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics
17. Upregulation of alpha GM-CSF-receptor in nonatopic asthma but not in atopic asthma
18. The relationship between inflammation and structural changes in the airways of the lower and upper respiratory tract [dissertation]. Comprehensive summaries of Uppsala dissertations from the faculty of medicine 932
19. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics
20. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes
21. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid
22. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity
23. Reactivity of monoclonal antibodies EG1 and EG2 with eosinophils and their granule proteins
24. Repeatability of measures of inflammatory cell number in bronchial biopsies in atopic asthma
25. Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies
26. Damage of the airway epithelium and bronchial reactivity in patients with asthma
27. Expression of laminins in the airways in various types of asthmatic patients: A morphometric study
28. Subepithelial fibrosis in the bronchi of asthmatic
29. Netutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema
30. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma
31. Histopathologic features of early and progressive asthma
32. The role of eosinophils in the pathophysiology of asthma
33. Asymptomatic airway hyperresponsiveness: Relationships with airway inflammation and remodelling
34. The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma
35. Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine
36. Expression of growth factors and remodelling of the airway wall in bronchial asthma
37. Eosinophil-associated TGF-beta 1 mRNA expression and airways fibrosis in bronchial asthma
38. Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease
39. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids
40. Increased levels of elastase and alpha1-antitrypsin in sputum of asthmatic patients
41. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation
42. Morphometry of the subepithelial circulation in sheep airways
43. Is asthma a vascular disorder?
44. Small airways dimensions in asthma and in chronic obstructive pulmonary disease
45. Increased vascularity of the bronchial mucosa in mild asthma
46. Bronchial angiogenesis in severe glucocorticoid-dependent asthma
47. Vascularity in asthmatic airways: Relation to inhaled steroid dose
48. Airway mucosal inflammation even in patients with newly diagnosed asthma
49. Increased goblet cell mucin content in mild and moderate asthma
50. Platelet-activating factor induces goblet cell hyperplasia and mucin gene expression in airways
51. Epidermal growth factor system regulates mucin production in airways
52. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway
53. A novel role for murine IL-4 in vivo: Induction of MUC5AC gene expression and mucin hypersecretion
54. Interleukin-13: Central mediator of allergic asthma
55. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma
56. The structure of large and small airways in nonfatal and fatal asthma
57. Functional significance of increased airway smooth muscle in asthma and COPD
58. Myofibroblasts and sub-epithelial fibrosis in bronchial asthma
59. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis
60. Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid
61. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma
62. Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways
63. Airway mucosa: Secretory cells, mucus and mucin genes
64. Localization and up-regulation of mucin (MUC2) gene expression in human nasal biopsies of patients with cystic fibrosis